Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity candidates
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity……
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…
Obesity Video Recap—December 9, 2025
This biweekly obesity video recap covers major GLP-1 therapeutic advances,…
Obesity Video Recap—November 25, 2025
This biweekly obesity video recap covers late-stage obesity trial readouts,…
Obesity Video Recap—November 11, 2025
This biweekly obesity video recap reviews major moves shaping the obesity and…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…
Obesity Today — October 28, 2025
Catch the latest obesity news, featuring industry updates, clinical progress,…
Obesity Video Recap — October 28, 2025
Join us for this biweekly roundup of obesity news, where we summarize important…
Obesity Today—October 21, 2025
Stay updated with this week’s obesity news, covering key developments and…
Endocrinology Video Recap — October 21, 2025
In this video, we take a closer look at the newest updates in Endocrinology.…
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…
Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to…